Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case­control study

Ichihara, Maria Y. T; Rodrigues, Laura C; Santos, Carlos A. S. Teles; Teixeira, Maria da Gloria L. C; Jesus, Sandra R. de; Matos, Sheila M. Alvim de; Leite, Jose P. Gagliardi; Barreto, Maurício L.
Artículo en Inglés | ARCA | ID: arc-10819

Documentos relacionados

  1. Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
  2. Microbiota-Derived Extracellular Vesicles as a Postbiotic Strategy to Alleviate Diarrhea and Enhance Immunity in Rotavirus-Infected Neonatal Rats.
  3. Rotavirus incapable of NSP6 expression can cause diarrhea in suckling mice.
  4. Immunoinformatics-guided design of a multi-valent vaccine against Rotavirus and Norovirus (ChRNV22).
  5. Recovery of Recombinant Rotaviruses by Reverse Genetics.
  6. Duration of Postdiarrheal Enteric Pathogen Carriage in Young Children in Low-resource Settings.
  7. Isolation and characterization of a G9P[23] porcine rotavirus strain AHFY2022 in China.
  8. Genetic diversity of G9, G3, G8 and G1 rotavirus group A strains circulating among children with acute gastroenteritis in Vietnam from 2016 to 2021.
  9. Rotavirus-mediated DGAT1 degradation: A pathophysiological mechanism of viral-induced malabsorptive diarrhea.
  10. Rotavirus Vaccine Trials in International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and Future Use of the Vaccine in Bangladesh.